Vetoryl 30 mg – Trilostane Capsules for Dogs

Vetoryl 30 mg capsules contain Trilostane, an adrenocortical suppressant used in the treatment of Cushing’s syndrome (hyperadrenocorticism) in dogs. It helps regulate the overproduction of cortisol caused by either pituitary-dependent or adrenal-dependent disease.
By reducing cortisol synthesis, Vetoryl improves quality of life in affected dogs — alleviating symptoms such as excessive thirst and urination, panting, abdominal enlargement, and coat thinning.

Key Benefits

• Clinically proven control of Cushing’s syndrome

• Reduces excessive cortisol levels to restore hormonal balance

• Improves appetite, energy, coat quality, and overall vitality

• Safe and effective for long-term therapy under veterinary supervision

• Manufactured to Dechra’s global veterinary standards

Active Ingredient (per capsule)

• Trilostane – 30 mg

Indications

For the treatment of:

• Pituitary-dependent hyperadrenocorticism (PDH)

• Adrenal-dependent hyperadrenocorticism (ADH)

Dosage & Administration

• Administer once daily with food or as directed by a licensed veterinarian.

• The initial recommended dose is approximately 2 mg/kg, adjusted according to clinical response and follow-up testing.

• Capsules must be administered whole — do not divide or open.

• Regular monitoring of cortisol and electrolyte levels is essential.

Precautions

• For oral use in dogs only.

• Do not use in dogs with liver, kidney, or heart disease, or in pregnant or lactating animals.

• Monitor for potential adverse effects such as vomiting, diarrhea, lethargy, or loss of appetite.

• Women who are pregnant or may become pregnant should avoid handling capsules.

Packaging

30 hard gelatin capsules (30 mg each)

Storage

Store below 25 °C, in a dry, locked location, away from direct sunlight and children.

Restore hormonal balance and vitality in dogs with Vetoryl 30 mg — the trusted Trilostane-based therapy for safe, effective, and clinically supported management of Cushing’s syndrome.